Leser–Trélat sign associated with lung cancer: a case report and review of the literature
- 1Department of Dermatology, The First People’s Hospital of Shuangliu District, West China (Airport) Hospital of Sichuan University
Abstract
The Leser–Trélat sign is a rare paraneoplastic dermatosis characterized by the abrupt development of multiple seborrheic keratoses within a short period and its association with visceral malignancies. Although gastrointestinal adenocarcinoma is the most commonly reported associated malignancy, lung cancer has increasingly been recognized as a possible underlying tumor. We report a case of a 62-year-old man who developed eruptive seborrheic keratoses on the neck, anterior chest, and back in conjunction with the diagnosis of minimally invasive adenocarcinoma of the right upper lobe. We additionally reviewed eight previously reported cases of lung cancer-associated Leser–Trélat sign and summarized their clinical characteristics. Notably, the paraneoplastic manifestation developed at an exceptionally early tumor stage (T1a(mi)N0Mx), suggesting that the Leser–Trélat sign may occur even in minimally invasive pulmonary adenocarcinoma. Adenocarcinoma was the predominant histological subtype among these cases (6 of 9), further suggesting a potential association between the Leser–Trélat sign and adenocarcinoma. Clinicians should be aware of this cutaneous marker, as its recognition may contribute to the early detection of occult malignancies.
Related
- Pigmented purpura dermatosis associated with compounded semaglutide: A case report and literature review of medication-associated pigmented purpuric dermatosis
- Margarita Dermatitis Revisited: A Case Report and Literature Review of Lime-Associated Phytophotodermatitis
- Systemic Mastocytosis With Associated Acute Myeloid Leukemia Identified After Induction Therapy: A Case Report and Literature Review
- CFTR variant-associated hereditary pancreatitis complicated by diabetes mellitus: a case report and literature review
- Diagnosis and minimally invasive surgical treatment of peritoneal dialysis-associated pleuroperitoneal fistula: A case report and literature review.
BibTeX
@article{xiong2026lesertrélat,
title = {{Leser–Trélat sign associated with lung cancer: a case report and review of the literature}},
author = {Mei Xiong and Lengping Chen and Junwu Zhou},
journal = {Frontiers in Oncology},
year = {2026},
month = oct,
doi = {10.3389/fonc.2026.1995820},
url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.1995820/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Leser–Trélat sign associated with lung cancer: a case report and review of the literature
AU - Mei Xiong
AU - Lengping Chen
AU - Junwu Zhou
PY - 2026
DA - 2026/10/29
JO - Frontiers in Oncology
DO - 10.3389/fonc.2026.1995820
UR - https://www.frontiersin.org/articles/10.3389/fonc.2026.1995820/full
AB - The Leser–Trélat sign is a rare paraneoplastic dermatosis characterized by the abrupt development of multiple seborrheic keratoses within a short period and its association with visceral malignancies. Although gastrointestinal adenocarcinoma is the most commonly reported associated malignancy, lung cancer has increasingly been recognized as a possible underlying tumor. We report a case of a 62-year-old man who developed eruptive seborrheic keratoses on the neck, anterior chest, and back in conjunction with the diagnosis of minimally invasive adenocarcinoma of the right upper lobe. We additionally reviewed eight previously reported cases of lung cancer-associated Leser–Trélat sign and summarized their clinical characteristics. Notably, the paraneoplastic manifestation developed at an exceptionally early tumor stage (T1a(mi)N0Mx), suggesting that the Leser–Trélat sign may occur even in minimally invasive pulmonary adenocarcinoma. Adenocarcinoma was the predominant histological subtype among these cases (6 of 9), further suggesting a potential association between the Leser–Trélat sign and adenocarcinoma. Clinicians should be aware of this cutaneous marker, as its recognition may contribute to the early detection of occult malignancies.
SN - 2234-943X
ER -